12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Deals

Cardiogenesis, CryoLife deal

CryoLife will acquire Cardiogenesis for $0.46 per share, or about $22 million in cash. The price is a 43% premium to Cardiogenesis' close of $0.32 on March 28, before the deal was announced. The deal, which...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >